Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis
心肌梗死后精神应激与心肌缺血:性别差异、机制和预后
基本信息
- 批准号:10227058
- 负责人:
- 金额:$ 77.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute myocardial infarctionAdverse eventAffectAgeAge-YearsAmericanAreaBlood VesselsCardiovascular systemCause of DeathCessation of lifeCharacteristicsChronicClinicalCommunitiesCoronary ArteriosclerosisCoronary heart diseaseDataDiseaseEmotionalEmotional StressEmotionsEndotheliumEquilibriumEventFunctional disorderFundingGoalsHeart failureHomeHospitalizationImmuneInflammationInflammatoryLaboratoriesLifeLinkMeasuresMental DepressionMethodsModalityMonitorMyocardial InfarctionMyocardial IschemiaMyocardial perfusionOutcomePathway interactionsPatientsPeripheralPhysiologyPovertyPreventionProcessPrognosisPrognostic FactorProtocols documentationPsyche structurePsychological StressRecurrenceRegulationReportingResearchRestRiskRisk FactorsSamplingScientific Advances and AccomplishmentsSeveritiesSex DifferencesSleep disturbancesStandardizationStressStress TestsStressful EventSymptomsTestingTroponinUnstable anginaWomanWorkWorkloadbaseclinical outcome assessmentclinically significantcohortearly life adversityearly onsetendothelial stem cellexperiencefollow-upheart disease preventionhemodynamicsimmune functioninjury and repairmenmortalitymyocardial injuryneglectolder womenperfusion imagingpost-traumatic symptomspsychosocialreconstructionrepairedresponsesexsocialstressorvasoconstrictionyoung woman
项目摘要
Young women with a myocardial infarction (MI) have emerged as a group in need of special study, as they have
higher mortality compared with men of similar age despite less severe disease. These disparities remain
unexplained and suggest sex differences in the pathophysiology, risk factors and prognostic factors of acute MI.
The psychosocial sphere is a largely neglected area for the prevention of ischemic heart disease in women. In
the previous funding period (R01 HL109413) we assembled a cohort of early-onset (≤60 years of age) post-MI
patients, 50% women, and sex- and age-matched community controls—the Myocardial Infarction and Mental
Stress (MIMS)2 study. We used a laboratory protocol to study mental stress-induced myocardial ischemia (MSI),
a marker of stress vulnerability and significant prognostic factor in people with coronary artery disease. We found
that young women with MI have twice the rate of MSI than men of similar age. We also found that the
mechanisms of MSI differ by sex. While in men MSI is primarily due to supply-demand mismatch, in women it is
driven by microvascular vasoconstriction.
Despite significant progress in our previous funding period, many questions still remain. First, the clinical
implications of MSI in women are unknown, since former studies have mostly examined men. Second, the
pathways through which MSI contributes to adverse events are unclear. Based on our data, processes
involving vascular and immune function could be especially important for women, but this has never been
tested. Third, the underlying mechanisms for the higher rate of MSI in young women are unclear. In addition to
differences in physiology, MSI could reflect differences in enduring daily life stressors and/or affect/emotions.
Building on this previous work, the goal of this competitive renewal is to clarify sex differences in pathways of
risk linking emotional stress to MSI and clinical outcomes in young post-MI patients. Within 8 months of MI,
300 new patients younger than 61 years, 50% women, will be tested in the lab for MSI using our established
protocol with myocardial perfusion imaging with the same modalities as MIMS2. Subjects will be monitored at
home for 1 week, and then followed for clinical events. The proposed sample (MIMS3) will augment our
existing cohort (MIMS2), doubling its size to 600 patients so as to make it suitable for the assessment of
clinical outcomes. The specific aims are: 1) Examine whether MSI is related to clinical outcomes in both
women and men (a composite endpoint of recurrent MI, unstable angina, heart failure hospitalization and
cardiovascular death). 2) Examine whether vascular responses to mental stress are related to the clinical
endpoint, including endothelium-dependent and microvascular function, and peripheral vasoconstriction; in an
exploratory fashion, we will also examine markers of autonomic dysregulation, inflammation, myocardial injury
and repair in response to mental stress. 3) Examine sex differences in stressful events and autonomic function
during daily life and their relation with MSI during one week of home monitoring.
年轻女性心肌梗死(MI)已成为一个需要特别研究的群体,因为他们
尽管疾病不太严重,但与年龄相仿的男性相比死亡率更高。这些差距仍然存在
提示急性心肌梗死的病理生理学、危险因素和预后因素存在性别差异。
在预防妇女缺血性心脏病方面,心理社会领域是一个很大程度上被忽视的领域。在
在上一个资助期(R 01 HL 109413),我们收集了一个早发性(≤60岁)MI后队列
患者,50%的女性,以及性别和年龄匹配的社区对照组-心肌梗死和精神病
压力(MIMS)2研究。我们使用实验室方案来研究精神应激诱导的心肌缺血(MSI),
是冠心病患者压力脆弱性的标志和重要的预后因素。我们发现
患有MI的年轻女性的MSI率是同龄男性的两倍。我们还发现
MSI的机制因性别而异。男性的MSI主要是由于供需不匹配,而女性的MSI则是由于
由微血管收缩驱动
尽管我们在上一个供资期间取得了重大进展,但仍然存在许多问题。第一,临床
MSI在女性中的意义尚不清楚,因为以前的研究主要是检查男性。二是
MSI导致不良事件的途径尚不清楚。基于我们的数据、流程
涉及血管和免疫功能可能对女性特别重要,但这从来没有
测试.第三,年轻女性MSI发生率较高的潜在机制尚不清楚。除了
在生理学上的差异,MSI可以反映在持久的日常生活压力和/或影响/情绪的差异。
在此之前的工作的基础上,这次竞争性更新的目标是澄清性别差异的途径,
在年轻心肌梗死后患者中,将情绪压力与MSI和临床结果联系起来的风险。MI后8个月内,
300名年龄小于61岁的新患者(50%为女性)将在实验室中使用我们建立的MSI检测方法进行MSI检测。
使用与MIMS 2相同的模式进行心肌灌注成像。受试者将在
回家1周,然后随访临床事件。建议的样本(MIMS 3)将增强我们的
现有队列(MIMS 2),将其规模扩大一倍至600名患者,以使其适合评估
临床结果。具体目的是:1)检查MSI是否与两种临床结局相关
女性和男性(复发性MI、不稳定型心绞痛、心力衰竭住院和
心血管死亡)。2)检查血管对精神压力的反应是否与临床
终点,包括内皮依赖性和微血管功能,以及外周血管收缩;
探索性的方式,我们还将检查自主神经失调,炎症,心肌损伤的标志物
并在精神压力下进行修复3)检查压力事件和自主神经功能的性别差异
在一周的家庭监测中,观察其与MSI的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viola Vaccarino其他文献
Viola Vaccarino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viola Vaccarino', 18)}}的其他基金
Sleep Disturbance as a Mechanism for Ischemic Heart Disease in PTSD
睡眠障碍是创伤后应激障碍 (PTSD) 患者缺血性心脏病的机制
- 批准号:
9263431 - 财政年份:2017
- 资助金额:
$ 77.57万 - 项目类别:
Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health
减少心血管健康不平等的多学科研究培训
- 批准号:
10090278 - 财政年份:2016
- 资助金额:
$ 77.57万 - 项目类别:
Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health
减少心血管健康不平等的多学科研究培训
- 批准号:
10364625 - 财政年份:2016
- 资助金额:
$ 77.57万 - 项目类别:
Multidisciplinary Research Training to Reduce Inequities in Cardiovascular Health
多学科研究培训减少心血管健康方面的不平等
- 批准号:
9266827 - 财政年份:2016
- 资助金额:
$ 77.57万 - 项目类别:
Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health
减少心血管健康不平等的多学科研究培训
- 批准号:
10658979 - 财政年份:2016
- 资助金额:
$ 77.57万 - 项目类别:
PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
创伤后应激障碍 (PTSD) 和缺血性心脏病进展:一项纵向双胞胎研究
- 批准号:
9109033 - 财政年份:2015
- 资助金额:
$ 77.57万 - 项目类别:
PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
创伤后应激障碍 (PTSD) 和缺血性心脏病进展:一项纵向双胞胎研究
- 批准号:
8984805 - 财政年份:2015
- 资助金额:
$ 77.57万 - 项目类别:
PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
创伤后应激障碍 (PTSD) 和缺血性心脏病进展:一项纵向双胞胎研究
- 批准号:
9268781 - 财政年份:2015
- 资助金额:
$ 77.57万 - 项目类别:
Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
心肌梗死后精神应激与心肌缺血:性别差异及机制
- 批准号:
8297317 - 财政年份:2012
- 资助金额:
$ 77.57万 - 项目类别:
Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
心肌梗死后精神应激与心肌缺血:性别差异及机制
- 批准号:
8675327 - 财政年份:2012
- 资助金额:
$ 77.57万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 77.57万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 77.57万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 77.57万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 77.57万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 77.57万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 77.57万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 77.57万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 77.57万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 77.57万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 77.57万 - 项目类别: